Cargando…
Ibandronate Treatment Before and After Implant Insertion Impairs Osseointegration in Aged Rats with Ovariectomy Induced Osteoporosis
Excessive decreases in bone volume (BV) and bone mineral density (BMD) can lead to osteoporosis, potentially hindering implant osseointegration. Bisphosphonates are commonly used to combat osteoporosis by slowing osteoclast‐mediated resorption; however, functional osteoclasts are integral to bone re...
Autores principales: | Lotz, Ethan M., Cohen, David J., Ellis, Regan A., Wayne, Jennifer S., Schwartz, Zvi, Boyan, Barbara D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659452/ https://www.ncbi.nlm.nih.gov/pubmed/31372590 http://dx.doi.org/10.1002/jbm4.10184 |
Ejemplares similares
-
Evaluation of Osseointegration around Tibial Implants in Rats by Ibandronate-Treated Nanotubular Ti-32Nb-5Zr Alloy
por: Nepal, Manoj, et al.
Publicado: (2014) -
Quarterly intravenous injection of ibandronate to treat osteoporosis in postmenopausal women
por: Sambrook, Philip
Publicado: (2007) -
Ibandronate: the first once-monthly oral bisphosphonate for treatment of postmenopausal osteoporosis
por: Bauss, Frieder, et al.
Publicado: (2006) -
Predictors of Ibandronate Efficacy for the Management of Osteoporosis: A Meta-Regression Analysis
por: Ma, Zeren, et al.
Publicado: (2016) -
A prospective comparative study of intravenous alendronate and ibandronate for the treatment of osteoporosis
por: Horikawa, Akira, et al.
Publicado: (2019)